These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 430792)

  • 1. Drug interaction between ascorbic acid and fluphenazine.
    Dysken MW; Cumming RJ; Channon RA; Davis JM
    JAMA; 1979 May; 241(19):2008. PubMed ID: 430792
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of age and thioridazine on the in vitro binding of fluphenazine to normal human serum.
    Rowell FJ; Hui SM; Fairbairn AF; Eccleston D
    Br J Clin Pharmacol; 1980 Apr; 9(4):432-4. PubMed ID: 7378262
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistence of fluphenazine in plasma after decanoate withdrawal.
    Gitlin MJ; Midha KK; Fogelson D; Nuechterlein K
    J Clin Psychopharmacol; 1988 Feb; 8(1):53-6. PubMed ID: 3351000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low neuroleptic serum levels in patients receiving fluphenazine decanoate.
    Tune LE; Creese I; Coyle JT; Pearlson G; Snyder SH
    Am J Psychiatry; 1980 Jan; 137(1):80-2. PubMed ID: 6101523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of parent drug and metabolites in patients receiving oral and depot fluphenazine.
    Marder SR; Van Putten T; Aravagiri M; Hubbard JW; Hawes EM; McKay G; Midha KK
    Psychopharmacol Bull; 1989; 25(3):479-82. PubMed ID: 2626520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma fluphenazine levels in patients receiving two doses of fluphenazine decanoate.
    Marder SR; Hubbard JW; Van Putten T; Hawes EM; McKay G; Mintz J; May PR; Midha KK
    Psychopharmacol Bull; 1986; 22(1):264-6. PubMed ID: 3726072
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma fluphenazine levels measured by high-performance liquid chromatography in patients treated with depot injections.
    Jouen F; Verité P; André D; Colonna L; Boucly P
    Arzneimittelforschung; 1993 May; 43(5):509-11. PubMed ID: 8328993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of ascorbic acid and warfarin.
    Smith EC; Skalski RJ; Johnson GC; Rossi GV
    JAMA; 1972 Sep; 221(10):1166. PubMed ID: 4679014
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluphenazine plasma levels and clinical response.
    Mavroidis ML; Kanter DR; Hirschowitz J; Garver DL
    J Clin Psychiatry; 1984 Sep; 45(9):370-3. PubMed ID: 6381472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluphenazine plasma levels and clinical response.
    Marder SR; Van Putten T; Aravagiri M; Hawes EM; Hubbard JW; McKay G; Mintz J; Midha KK
    Psychopharmacol Bull; 1990; 26(2):256-9. PubMed ID: 2236467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma fluphenazine levels and clinical response in newly admitted schizophrenic patients.
    Van Putten T; Aravagiri M; Marder SR; Wirshing WC; Mintz J; Chabert N
    Psychopharmacol Bull; 1991; 27(2):91-6. PubMed ID: 1924666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subnanogram determination of fluphenazine in human plasma by gas chromatography mass spectrometry.
    McKay G; Hall K; Edom R; Hawes EM; Midha KK
    Biomed Mass Spectrom; 1983 Oct; 10(10):550-5. PubMed ID: 6652229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of erythorbic acid with ascorbic acid catabolism.
    Hornig D; Weiser H
    Int J Vitam Nutr Res; 1976; 46(1):40-7. PubMed ID: 1262134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of vitamin E and ascorbic acid (review).
    Chen LH
    In Vivo; 1989; 3(3):199-209. PubMed ID: 2519855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of ascorbic acid on the antibacterial activity of selected antibiotics and synthetic chemotherapeutic agents in in vitro conditions].
    Belicová A; Dobias J; Ebringer L; Krajcovic J
    Ceska Slov Farm; 2000 May; 49(3):134-8. PubMed ID: 10953458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluphenazine decanoate: plasma concentrations and clinical response [proceedings].
    Nasrallah HA; Rivera-Calimlin L; Rogol AD
    Psychopharmacol Bull; 1978 Jul; 14(3):46-7. PubMed ID: 353871
    [No Abstract]   [Full Text] [Related]  

  • 17. [The serum fluphenazine level in patients with schizophrenia and the results of long-term treatment].
    Szukalski B; Lipska B; Welbel L; Nurowska K
    Psychiatr Pol; 1987; 21(1):26-31. PubMed ID: 3615674
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of ascorbic acid and metallothionein-like fractions from equine renal cortex.
    Roosemont JL
    Arch Int Physiol Biochim; 1973 May; 81(2):385. PubMed ID: 4126238
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood serum concentration of long-acting fluphenazine in patients with various forms of schizophrenia].
    Pempkowiak L; Januszkiewicz-Grabiasowa A; Góra S
    Psychiatr Pol; 1979; 13(1):1-8. PubMed ID: 419224
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
    Wiles DH; Gelder MG
    Adv Biochem Psychopharmacol; 1980; 24():599-602. PubMed ID: 7405678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.